MedTrace Logo

Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT

NCT05289583 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2022-04-01

No results posted yet for this study

Summary

Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic information and pretreatment psychopathology during the days of their inpatient stay. Beyond that, changes of therapists were documented.

Conditions

  • Borderline Personality Disorder
  • Psychotherapy
  • Dropout

Interventions

BEHAVIORAL

Dialectical Behavior Therapy

DBT is a cognitive-behavioral treatment program that was developed to treat suicidal Patients with BPD (Linehan, 1993).

Sponsors & Collaborators

  • Evangelisches Krankenhaus Bielefeld gGmbH

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2021-12-31
Completion
2022-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05289583 on ClinicalTrials.gov